Learn More
Explore the Latest Advances in Nuclear Cardiology
Attend the 2019 SNMMI Mid-Winter and ACNM Annual Meeting, January 17-19 in Palm Springs, California and enhance your skills in new areas of nuclear cardiology as you learn directly from the experts developing the methods and leading their clinical application. Register today.
IDEAS Webinars and Resources
SNMMI offers a number of free resources on the Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study, including helpful links and on-demand webinars.
Targeted Radioisotope Therapy Webinar Series
The new technologies of radionuclide therapy are allowing for personalized treatment of various forms of cancer. Learn more about the clinical utility of these procedures and earn free CE credit.
Healthcare Provider
Welcome to our Healthcare Provider portal. Everything you need to understand the advantages and applications of nuclear medicine and molecular imaging in your practice. Find out more about ordering the right test for the right patient at the right time.
- What's New
- Disease-Specific Information
- Guidelines
- Ordering Information
- Other Resources
- Request a Speaker
SNMMI's Newly Approved Appropriate Use Criteria
Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.
NEW AUCs:
- Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
- Hepatobiliary Scintigraphy in Abdominal Pain
- FDG PET/CT Restaging and Response Assessment of Malignant Disease
- Bone Scintigraphy in Prostate and Breast Cancer
- Ventilation/Perfusion (V/Q) Imaging in Pulmonary Embolism
Disease-Specific Information
Oncology |
Cardiology
|
Neurology
|
Guidance
SNMMI has created guidelines to identify those elements of the procedure that are most important in obtaining a high-quality examination, Appropriate Use Criteria (AUC), and is working towards optimizing dose.
Guidelines
Appropriate Use Criteria
Dosimetry
Dose Optimization
Related Resources
NCCN's Guidelines Tabular Summary
NCCN Practice Guidelines Narrative Summary
Ordering Information
The SNMMI PET Center of Excellence has created a go-to resource with in-depth ordering information and printable materials related to PET and PET/CT, including:
-
Sample Request Forms
-
Sample Letters of Medical Necessity
-
Sample Reports from Nuclear Medicine Physician
-
CMS Decision Memos
Learn More
Other Resources
Request a Speaker
SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.
Outreach Speaker Request Form
Outreach Program
FAQs
- May 16, 2019 —
NRC Calls for Additional Feedback on Training and Experience Requirements for Radiopharmaceuticals Requiring a Written Directive
On Thursday May, 2, the U.S. Nuclear Regulatory Commission (NRC) published a notice in the Federal Register announcing a 30-day public comment period and two public meetings on the NRC staff’s draft approaches regarding training and experience requirements for administration of radiopharmaceuticals requiring a written directive.
(Government Relations News) - April 30, 2019 —
SNMMI Member Hosts Policymakers at Georgetown Hospital
On Thursday April 25th, distinguished SNMMI member Giuseppe Esposito, MD, alongside staff from SNMMI, and MITA hosted congressional staffers at Georgetown Hospital in Washington, DC.
(Government Relations News) - April 26, 2019 —
Nuclear Medicine Therapy Shows Long-Term Effectiveness for Malignant Neuroendocrine Tumors
A 12-year retrospective clinical study of patients who received peptide receptor radionuclide therapy for malignant neuroendocrine tumors demonstrates the long-term effectiveness of this treatment, which also allows patients to maintain a high quality of life. The study is featured in the April issue of The Journal of Nuclear Medicine.
(Press Release) - April 23, 2019 —
Courtney Lawhn-Heath Awarded 2019 Henkin Fellowship
SNMMI is pleased to announce that Courtney Lawhn-Heath, MD, has been selected as the recipient of the 2019 Robert E. Henkin Government Relations Fellowship.
(Government Relations News)
- Jun 22, 2019 -
Jun 25, 2019
—
SNMMI 2019 Annual Meeting
Anaheim Convention Center
Headquarter Hotel: Hilton Anaheim | Anaheim | - Jun 13, 2020 -
Jun 16, 2020
—
SNMMI 2020 Annual Meeting
New Orleans Ernest N. Morial Convention Center
Headquarter Hotel: New Orleans Marriott Downtown | New Orleans | - Jan 28, 2021 -
Jan 30, 2021
—
SNMMI 2021 Mid-Winter Meeting
Hyatt Regency San Francisco | San Francisco | - Jun 12, 2021 -
Jun 15, 2021
—
SNMMI 2021 Annual Meeting
Walter E. Washington Convention Center
Headquarter Hotel: Marriott Marquis Washington, DC | Washington | - Jun 11, 2022 -
Jun 14, 2022
—
SNMMI 2022 Annual Meeting
Vancouver Convention Centre
Co-Headquarter Hotels: Fairmont Waterfront and Pan Pacific | Vancouver | Canada
Featured Resources
- Legislative Issues
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
- Celebrate Women in Medicine Month
- Radiation Safety+ Review and Essentials
- Clincal Guidelines
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
- Nuclear Medicine and Molecular Imaging Week: October 6-12, 2019
Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.